| Literature DB >> 9070564 |
Abstract
Recent developments in the treatment of chronic heart failure have lead to the use of beta blockers to improve ventricular function and symptoms, and to reverse or slow pathologic remodeling of the failing heart. Little practical information exists in the literature on how to initiate this therapy and how to select the proper beta-blocking agent. This editorial examines which beta-blocking agents are best tolerated and why, and describes how best to initiate treatment with these agents.Entities:
Mesh：
Substances：
Year: 1997 PMID： 9070564 DOI： 10.1016/s0002-9149(96)00873-9
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778